Vesalius Cardiovascular Awarded Top Prize and $300,000 at 2019 Innovators' Challenge by VGH and UBC Hospital Foundation
Summary
Vesalius Cardiovascular Awarded Top Prize and $300,000 at 2019 Innovators Challenge by VGH and UBC Hospital Foundation Vancouver, BC, June 25, 2019--(T-Net)--Vesalius Cardiovascular has taken home the 2019 Innovators Challenge presented by the VGH and UBC Hospital Foundation, winning the top prize of $300,000. Led by Dr. Peter Skarsgard, Vesalius Cardiovascular has made tremendous advancements in mitral regurgitation technology through their implanted medical device that is delivered to the heart percutaneously (through a vein in the leg). The company specializes in designing, developing and commercializing biomedical devices for the treatment of cardiovascular disease, specifically mitral valve regurgitation (MR). The venture will be managed as a lean Research and Development Initiative, with a scientific feedback and inputs from our Board of some of BCs most prominent clinicians. The principles of surgical mitral valve repair are utilized, but sternotomy, heart-lung bypass, and cardiac arrest - components of an open heart operation - are not required.